These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5216149)

  • 21. [The percutaneous treatment of peripheral angiopathies].
    Juon M
    Dermatologica; 1965; 131(1):69-80. PubMed ID: 5836164
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current concepts on the use of vasopressor agents in case of shock].
    Lassner J
    Cah Anesthesiol; 1971 Apr; 19(3):359-63. PubMed ID: 5110189
    [No Abstract]   [Full Text] [Related]  

  • 23. Attempted therapeutic application of agents acting on alpha and beta adrenerging receptors in experimental cardiac shock.
    Bocian J; Mazurowa A; Musial W; Rosiek S
    Pol Med J; 1969; 8(2):418-25. PubMed ID: 5772802
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of cardiogenic shock: the pendulum continues to swing.
    Corday E
    Am J Cardiol; 1965 Oct; 16(4):615-7. PubMed ID: 5834485
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction.
    Binder MJ
    Am J Cardiol; 1965 Dec; 16(6):834-40. PubMed ID: 5846008
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasopressor-cardiotonic drugs in cardiac resuscitation.
    Jude JR; Neumaster T; Kfoury E
    Acta Anaesthesiol Scand Suppl; 1968; 29():147-63. PubMed ID: 5674565
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasopressor and vasodilator drugs in the treatment of shock.
    Bradley EC; Weil MH
    Mod Treat; 1967 Mar; 4(2):243-55. PubMed ID: 5592030
    [No Abstract]   [Full Text] [Related]  

  • 28. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacology of peripheral sympathomimetics & the conclusions drawn from it for the treatment of shock & collapse].
    SCHNEIDER KW
    Dtsch Med J; 1958 May; 9(5):236-9. PubMed ID: 13547916
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of shock using vaso- and coagulation-active substances. Behavior of tissue oxygen in the dog kidney under the influence of vaso- and coagulation-active substances].
    Lenz J; Hartel W; Linder MM; Muschaweck R
    Fortschr Med; 1972 Nov; 90(32):1199-201. PubMed ID: 4348841
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic effects of vasopressor agents.
    Morris RE; Graff TD; Robinson P
    Bull N Y Acad Med; 1966 Nov; 42(11):1007-22. PubMed ID: 5232121
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of shock.
    De Backer D
    Acta Clin Belg; 2011; 66(6):438-42. PubMed ID: 22338308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sympathomimetic amines of current use. Cardiocirculatory effect in normal dogs. Observations].
    Aquino AB
    Hospital (Rio J); 1968 Nov; 74(5):1543-52. PubMed ID: 5305332
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.
    WEIL MH; HOULE DB; BROWN EB; CAMPBELL GS; HEATH C
    Calif Med; 1958 Jun; 88(6):437-40. PubMed ID: 13536861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cardiogenic shock. I.
    Cohen LS
    Md State Med J; 1972 Sep; 21(9):26-8. PubMed ID: 5054523
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran.
    Cohn JN; Luria MH
    Arch Intern Med; 1965 Oct; 116(4):562-6. PubMed ID: 4284276
    [No Abstract]   [Full Text] [Related]  

  • 40. [Shock and its treatment wuth chemotherapeutic agents].
    Fujita M; Iwabuchi K
    Jibiinkoka; 1969 Oct; 40(10):843-50. PubMed ID: 5812656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.